BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10425363)

  • 21. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat.
    Frantz SW; Beskitt JL; Tallant MJ; Zourelias LA; Ballantyne B
    Xenobiotica; 1996 May; 26(5):515-39. PubMed ID: 8736063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of renal failure on intestinal clearance of ciprofloxacin in rats.
    Dautrey S; Rabbaa L; Laouari D; Lacour B; Carbon C; Farinotti R
    Antimicrob Agents Chemother; 1999 Mar; 43(3):678-80. PubMed ID: 10049287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of the new pyrimidine derivative NS-7, a novel Na+/Ca2+ channel blocker. 1st communication: plasma concentrations and excretions after a single intravenous 14C-NS-7 injection to rats, dogs and monkeys.
    Nonaka K; Tsujioka T; Tougou K; Mukai H
    Arzneimittelforschung; 2003; 53(9):612-20. PubMed ID: 14558434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disposition of creatinine and urea in bilaterally nephrectomized rats.
    Watanabe J; Hirate J; Iwamoto K; Ozeki S
    J Pharmacobiodyn; 1981 Aug; 4(8):596-603. PubMed ID: 7299623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cyclosporin on the pharmacokinetics of propranolol after intravenous and oral administration to control rats and to rats with uranyl nitrate-induced acute renal failure.
    Lee YH; Ku YS
    J Pharm Pharmacol; 1999 Oct; 51(10):1149-54. PubMed ID: 10579686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of renal failure on ciprofloxacin pharmacokinetics in rats.
    Nouaille-Degorce B; Veau C; Dautrey S; Tod M; Laouari D; Carbon C; Farinotti R
    Antimicrob Agents Chemother; 1998 Feb; 42(2):289-92. PubMed ID: 9527774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism, pharmacokinetics and excretion of the GABA(A) receptor partial agonist [(14)C]CP-409,092 in rats.
    Kamel A; Obach RS; Tseng E; Sawant A
    Xenobiotica; 2010 Jun; 40(6):400-14. PubMed ID: 20334492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonlinear oral pharmacokinetics of the alpha-antagonist 4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-[4-(morpholinocarbonyl)-perhydro-1,4-diazepin-1-yl]quinoline in humans: use of preclinical data to rationalize clinical observations.
    Harrison A; Betts A; Fenner K; Beaumont K; Edgington A; Roffey S; Davis J; Comby P; Morgan P
    Drug Metab Dispos; 2004 Feb; 32(2):197-204. PubMed ID: 14744941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of oral and intravenous administration of digoxin after intestinal ischemia-reperfusion.
    Ogura J; Maruyama H; Kobayashi M; Itagaki S; Iseki K
    Biol Pharm Bull; 2010; 33(5):922-5. PubMed ID: 20460779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereoselective pharmacokinetics of atenolol in the rat: influence of aging and of renal failure.
    Belpaire FM; Rosseel MT; Vermeulen AM; De Smet F; Bogaert MG
    Mech Ageing Dev; 1993 Feb; 67(1-2):201-10. PubMed ID: 8469031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of the new pyrimidine derivative NS-7, a novel Na+/Ca2+ channel blocker. 2nd communication: tissue distributions, placental transfer and milk secretion of radioactivity after a single intravenous 14C-NS-7 injection to rats.
    Nonaka K; Tsujioka T; Tougou K; Mukai H
    Arzneimittelforschung; 2003; 53(10):695-700. PubMed ID: 14650361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of unilateral nephrectomy on the pharmacokinetics of amikacin in humans.
    Drozdzik M; Domanski L; Wojcicki J; Gawronska-Szklarz B; Machoy P; Pudlo A
    J Pharm Pharmacol; 2002 Apr; 54(4):509-14. PubMed ID: 11999128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased endothelin excretion in rats with renal failure induced by partial nephrectomy.
    Brooks DP; Contino LC; Storer B; Ohlstein EH
    Br J Pharmacol; 1991 Dec; 104(4):987-9. PubMed ID: 1810606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased release of atrial natriuretic peptide by the atria of rats with experimental renal failure.
    Wong NL; Wong EF
    Nephron; 1991; 57(1):89-93. PubMed ID: 1828542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacokinetics of Casodex in prostate cancer patients after single and during multiple dosing.
    Cockshott ID; Cooper KJ; Sweetmore DS; Blacklock NJ; Denis L
    Eur Urol; 1990; 18 Suppl 3():10-7. PubMed ID: 2094606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal vascular structural properties and their alterations by removal of uraemic toxins in a rat model of chronic kidney disease.
    Yamazaki H; Tomoda F; Koike T; Kinuno H; Sugimori H; Inoue H; Bannai K; Sugano M; Nishijima F
    Clin Exp Pharmacol Physiol; 2014 Mar; 41(3):238-45. PubMed ID: 24471839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-Dose Pharmacokinetics and Safety of Meropenem-Vaborbactam in Subjects with Chronic Renal Impairment.
    Rubino CM; Bhavnani SM; Loutit JS; Lohse B; Dudley MN; Griffith DC
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.